Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”

Division of Pediatric Hematology/Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan Tang-Her Jaing
Division of Pediatric Hematology/Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan Tang-Her Jaing
Haematologica Early view Sep 17, 2026 https://doi.org/10.3324/haematol.2026.301889

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2026.301889
 
Published
2026-09-17
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
48
PDF Downloads
15
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online